Preprint · OA
via OpenAlex
Immunomodulation By Therapeutic Mesenchymal Stromal Cells (MSC) Is Triggered Through Phagocytosis of MSC By Monocytic Cells
S Witte, Franka Luk, Jesús María Sierra-Párraga, Madhu Gargesha, Ana Merino, Sander S. Korevaar, Abhirami Shankar, Lisa O’Flynn, Steve Elliman, Debashish Roy, Michiel G.H. Betjes, Philip N. Newsome, Carla C. Baan, Martin J. Hoogduijn
Stem Cells · 2018 · ▲ 512 citations
Abstract
Abstract Mesenchymal stem or stromal cells (MSC) are under investigation as a potential immunotherapy. MSC are usually administered via intravenous infusion, after which they are trapped in the lungs and die and disappear within a day. The fate of MSC after their disappearance from the lungs is unknown and it is unclear how MSC realize their immunomodulatory effects in their short lifespan. We examined immunological mechanisms determining the fate of infused MSC and the immunomodulatory response associated with it. Tracking viable and dead human umbilical cord MSC (ucMSC) in mice using Qtracker beads (contained in viable cells) and Hoechst33342 (staining all cells) revealed that viable ucMSC were present in the lungs immediately after infusion. Twenty-four hours later, the majority of ucMSC were dead and found in the lungs and liver where they were contained in monocytic cells of predominantly non-classical Ly6Clow phenotype. Monocytes containing ucMSC were also detected systemically. In vitro experiments confirmed that human CD14++/CD16- classical monocytes polarized toward a non-classical CD14++CD16+CD206+ phenotype after phagocytosis of ucMSC and expressed programmed death ligand-1 and IL-10, while TNF-α was reduced. ucMSC-primed monocytes induced Foxp3+ regulatory T cell formation in mixed lymphocyte reactions. These results demonstrate that infused MSC are rapidly phagocytosed by monocytes, which subsequently migrate from the lungs to other body sites. Phagocytosis of ucMSC induces phenotypical and functional changes in monocytes, which subsequently modulate cells of the adaptive immune system. It can be concluded that monocytes play a crucial role in mediating, distributing, and transferring the immunomodulatory effect of MSC.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1002/stem.2779
- Canonical
- link ↗
- Fetched
- 2026-06-21 MST
Cite this
APA
Witte, S., Luk, F., Sierra-Párraga, J.M., Gargesha, M., Merino, A., Korevaar, S.S., Shankar, A., O’Flynn, L., Elliman, S., Roy, D., Betjes, M.G., Newsome, P.N., Baan, C.C., & Hoogduijn, M.J. (2018). Immunomodulation By Therapeutic Mesenchymal Stromal Cells (MSC) Is Triggered Through Phagocytosis of MSC By Monocytic Cells. <em>Stem Cells</em>. https://doi.org/10.1002/stem.2779
Vancouver
Witte S, Luk F, Sierra-Párraga JM, Gargesha M, Merino A, Korevaar SS, et al. Immunomodulation By Therapeutic Mesenchymal Stromal Cells (MSC) Is Triggered Through Phagocytosis of MSC By Monocytic Cells. Stem Cells. 2018. doi:10.1002/stem.2779.
BibTeX
@unpublished{s2018Immuno,
title = {Immunomodulation By Therapeutic Mesenchymal Stromal Cells (MSC) Is Triggered Through Phagocytosis of MSC By Monocytic Cells},
author = {S Witte and Franka Luk and Jesús María Sierra-Párraga and Madhu Gargesha and Ana Merino and Sander S. Korevaar and Abhirami Shankar and Lisa O’Flynn and Steve Elliman and Debashish Roy and Michiel G.H. Betjes and Philip N. Newsome and Carla C. Baan and Martin J. Hoogduijn},
journal = {Stem Cells},
year = {2018},
doi = {10.1002/stem.2779},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Scandinavian Journal of Immunology 2007
Open access · OA
Mesenchymal Stem Cells Stimulate Antibody Secretion in Human B Cells
International Journal of Molecular Sciences 2021
Open access · CC-BY
Human MSC-Derived Exosomes Reduce Cellular Senescence in Renal Epithelial Cells
Frontiers in Immunology 2019
Open access · CC-BY
Immunomodulation by Mesenchymal Stem Cells (MSCs): Mechanisms of Action of Living, Apoptotic, and Dead MSCs
Aging and Disease 2020
Open access · CC-BY
Transplantation of ACE2- Mesenchymal Stem Cells Improves the Outcome of Patients with COVID-19 Pneumonia
Frontiers in Cell and Developmental Biology 2020
Open access · CC-BY
Mesenchymal Stem Cell Senescence and Rejuvenation: Current Status and Challenges
Stem Cells Translational Medicine 2013
Open access · OA